Kromek Group PLC Directorate Changes (7767I)
December 16 2020 - 2:00AM
UK Regulatory
TIDMKMK
RNS Number : 7767I
Kromek Group PLC
16 December 2020
16 December 2020
Kromek Group plc
("Kromek" or the "Group")
Directorate Changes
Kromek (AIM: KMK), a worldwide supplier of detection technology
focusing on the medical, security screening and nuclear markets, is
pleased to announce the appointment of Mr Berry Beumer, Chief
Operating Officer ("COO"), as an Executive Director of the Group
with immediate effect. Furthermore, Mr Rakesh Sharma OBE, who
joined the Group as a Non-executive Director in October 2020, will
replace Sir Peter Williams CBE as Non-executive Chairman, who is
retiring from the Board on 1 January 2021.
Mr Albertus ("Berry") Beumer, aged 56, is a technology business
executive with extensive experience of delivering revenue growth in
the analytical instrument, high-frequency communications equipment
and optoelectronic and semiconductor materials industries. Since
joining Kromek as COO in 2015, based in the Group's Pennsylvania
facility, he has played an instrumental role in the growth of the
business through the expansion of Kromek's US customer base and
operations in both medical imaging and nuclear detection. Prior to
Kromek, he held a number of senior roles at businesses in Europe
and the US, including 14 years as Vice President, Sales and
Marketing at XOS, Inc., part off Danaher Inc., a leading
manufacturer of application-specific x-ray analysers, where he was
responsible for driving the strategic direction of their x-ray
elemental technology business.
Rakesh Sharma OBE, Chairman Designate of Kromek, said: "It is a
great honour to succeed Sir Peter as Chairman. I thank him for his
valuable contribution which has enabled Kromek to truly transform
during his tenure, and we wish him all the best in his retirement.
I am also pleased to welcome Berry to the Board. He has played a
fundamental role in our growth as part of the executive team and we
look froward to further benefitting from his expertise in his new
role. Kromek is an ambitious company with advanced technology,
extensive IP and a foothold in some of the most important markets
today. We are excited about the future and delivering on our plans
to secure sustainable growth and shareholder value."
Sir Peter Williams added: "It has been a pleasure to be a part
of Kromek's journey as it has matured and scaled up over recent
years into a truly international business with diversified revenue
streams. As I retire, I leave the role of Chairman in the very
capable hands of Rakesh who brings tremendous experience in
overseeing the growth of international hi-tech engineering and
manufacturing businesses. I also congratulate Berry Beumer on
joining the Board and, following Paul Farquhar's recent
appointment, I leave Kromek with a refreshed and powerful team at
the helm under Arnab Basu's leadership. I will be following the
business closely and look forward to watching its continued
progress."
Mr Beumer holds 80,000 ordinary shares in the Group,
representing 0.02% of the issued share capital. There are no other
matters required to be disclosed pursuant to paragraph (g) of
Schedule Two to the AIM Rules for Companies as regards Mr Beumer's
appointment.
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO
Paul Farquhar, CFO +44 (0)1740 626 060
Cenkos Securities plc (Nominated Adviser
and Broker)
Max Hartley (NOMAD)
Julian Morse (Sales) +44 (0)20 7397 8900
Luther Pendragon (PR)
Harry Chathli
Claire Norbury
Alexis Gore
Joe Quinlan +44 (0)20 7618 9100
About Kromek Group plc
Kromek Group plc is a technology group (global HQ in County
Durham) and a leading developer of high performance radiation
detection products based on cadmium zinc telluride ("CZT") and
other advanced technologies. Using its core technology platforms,
Kromek designs, develops and produces x-ray and gamma ray imaging
and radiation detection products for the medical, security
screening and nuclear markets.
The Group's products provide high resolution information on
material composition and structure and are used in multiple
applications, ranging from the identification of cancerous tissues
to hazardous materials, such as explosives, and the analysis of
radioactive materials.
The Group's business model provides a vertically integrated
technology offering to customers, from radiation detector materials
to finished products or detectors, including software, electronics
and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and
Pennsylvania), and is selling internationally through a combination
of distributors and direct OEM sales.
Currently, the Group has over one hundred full-time employees
across its global operations. Further information on Kromek Group
is available at www.kromek.com and
https://twitter.com/kromekgroup.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOABELLFBLLEFBF
(END) Dow Jones Newswires
December 16, 2020 02:00 ET (07:00 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Apr 2024 to May 2024
Kromek (LSE:KMK)
Historical Stock Chart
From May 2023 to May 2024